Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells

Yaoxue Xuebao

Volumn 43, Issue 5, 2008, Pages 461-466

  Wang, Tian Xiao ^a   Yang, Xiao Hong ^b  

^a HENAN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Isotetrandrine; MCF 7 DOX cell; Multidrug resistance; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLISOQUINOLINE DERIVATIVE; DOXORUBICIN; GLYCOPROTEIN P; HERBACEOUS AGENT; RHODAMINE 123; TETRANDRINE;

ARTICLE; BREAST TUMOR; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; GENE; GENE EXPRESSION REGULATION; HUMAN; ISOLATION AND PURIFICATION; MAHONIA; MEDICINAL PLANT; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; PLANT STEM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZYLISOQUINOLINES; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; MAHONIA; P-GLYCOPROTEIN; PLANT STEMS; PLANTS, MEDICINAL; RHODAMINE 123;

EID: 47249149289     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter [J]. Annu Rev Biochem, 1993,62:385-427.
2. 3H] vinblastine transport by isolated vesicles [J]. Biochim Biophys Acta, 1991,1061:106-110.
3. Zeng XY, Lao BS, Dong YL, et al. Extraction and analysis of 1R, 1S-isotetrandrine from Mohania. Beali (Fort) [J]. J Instrum Anal ( ), 2003, 22.-89-91.
4. Chen B, Wang W. Advance of research tetrandrine in the treatment of tumor [J]. Chin J Integ Tra Wes Med ( ), 2001,21:636-638.
5. Xu WL, Jiang YW, Wang FC, et al. Reversal mechanism of tetrandrine on multidrug resistance in leukemia cell line K562/ADM [J]. Practic J Cancer ( ), 2003,18:347-349.
6. Xu WL, Ao DF. Clinical study of tetrandrine reversing multidrug resistance of tumor cells of blood system [J]. Chin J Int Med () , 2001,40:631-633.
7. Wadhwa J, Szydlo RM, Apperley JF, et al. Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia [J]. Blood, 2002,99:2304-2309.
8. Marks DC, Belov L, Davey MW, et al. The MTT viability assay for cytotoxicity esting in multidrug-resistant human leukemic cells [J]. Leukemia Res, 1992,16:1165-1173.
9. Xia CY, Liu JY, Liao JH. The comparative study of proliferative activity of two human pulmonary carcinoma cell lines between cultured cells and tumor cells implanted in nude mice [J]. Chin J Clin Exp Pathol ( ), 1997,13:151-152.
10. Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins [J]. Cell, 1986,47:371-380.
11. Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter in AML; molecular regulation and therapeutic strategies [J]. Blood, 2004,104:1940-1951.
12. Green LJ, Marder P, Slapak CA. Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells [J]. Biochem Pharmacol, 2001,61:1393-1399.